TP53 and neoplasm: Based on our signature and previous studies, the patients in the high-risk group had extensive genomic alterations and high tumor heterogeneity, reflected in the indicators including high CNA scores, high TP53 mutation frequencies, high LOH scores, high HRD scores, high MATH scores, high RNAss, high ploidy, and high tumor neoantigen count.